Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/02/109   
Active ingredient: Oregovomab
Indication: Treatment of ovarian cancer
Sponsor: ViRexx International Corp. Limited
1 Main Street, Blessington, County Wicklow, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
1/08/2002 Orphan designation EMEA/OD/019/02 (2002)3014 of 30/07/2002
25/10/2004 Change of name and/or address of sponsor
4/05/2007 Transfer of orphan designation EMEA/OD/019/02/T/01 (2007)2008 of 2/05/2007